Clinical trials
Phase 1/2 Nasopharyngeal Carcinoma trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chinese Academy of Medical Sciences | 1 |
| Guangxi Medical University | 1 |
| Innolake Biopharm | 1 |
| Jiangsu HengRui Medicine Co., Ltd. | 1 |
| Shanghai Junshi Bioscience Co., Ltd. | 1 |
| Sun Yat-sen University | 1 |
| The Second Hospital of Nanjing Medical University | 1 |
| Wei Jiang | 1 |
| Xiaoyi Huang | 1 |
| Yang Yang | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Nasopharyngeal Carcinoma | 10 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Carcinoma, Renal Cell | 1 |
| Colorectal Neoplasms | 1 |
| Endometrial Neoplasms | 1 |
| Esophageal Squamous Cell Carcinoma | 1 |
| Head and Neck Neoplasms | 1 |
| Hodgkin Disease | 1 |
| Lung Neoplasms | 1 |
| Lymphoma, Large B-Cell, Diffuse | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.